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Abstract
Hospital acquired infections, particularly antibiotic resistant infections, are a growing concern
due to their infection and mortality rate, as well as their growing economic burden, and it has
been estimated that by the year 2050 the associated mortality rate will be around 10 million
deaths per year. A solution to this is better means of prevention, and amphiphiles, compounds
with at least one hydrophilic head group and at least one hydrophobic tail, are promising
candidates for stopping the spread of infectious bacteria. Novel amphiphiles with two
bipyridinium head groups, separated by a hydrophobic carbon spacer of varying lengths, and
each with a hydrophobic carbon tail of varying lengths, were synthesized and tested for their
antibacterial properties using minimum inhibitory concentrations, time kill, and biofilm
disruption assays. The amphiphiles were tested on select bacterial species known to be associated
with hospital acquired infections. The amphiphiles, 10-B-12-B-10, 10-B-14-B-10, and 12-B-14B-12 were shown to be the most effective when considering all three antibacterial assays. Both
10-B-12-B-10 and 12-B-14-B-12 had over 70% biofilm disruptions at concentrations of 63μM
and 125μM, respectively, exceeding the disruption capabilities of tobramycin at its peak
concentrations. Both 10-B-12-B-10 and 10-B-14-B-10 were able to kill three out of the four
bacteria tested in 5 minutes or less, with S. aureus being killed in 30 minutes, while 8-B-16-B-8
and 10-B-12-B-10 were able to kill two out of the four tested bacteria in less than one minute. In
the 10-tailed series at spacer lengths of 12 and 14 carbons, the growth of all tested bacteria was
inhibited at concentrations of 2μM to 4μM. Scanning electron microscopy (SEM) of tested
strains showed poration and lysis of the cell membranes was likely the mechanism of action of
these amphiphiles. These results can be useful for the development of antiseptics and
disinfectants that can effectively prevent the spread of antibacterial resistant bacteria.

viii

1
Chapter 1: Introduction
Hospital Acquired Infections
Hospital acquired infections are a major concern due to the high incidence of antibiotic resistant
infections in patients (Golkar, 2013). According to the CDC, in 2014 4% of inpatients had at
least one hospital acquired infection, with leading causes including pneumonia, surgical site,
gastrointestinal, urinary tract, and bloodstream infections. The leading pathogens included C.
difficile, Staphylococcus aureus, Klebsiella, and Escherichia coli (Monegro & Regunath, 2020),
and antibiotic resistance in hospital acquired infections has shown a dramatic rise in recent years
due to the overuse of antibiotics (Mehrad, et al., 2018).
Antibiotics have saved millions of lives and have become a staple of modern medicine
through their ability to target bacteria specifically, rather than human tissue or its products
(Gould, 2013). Unfortunately, long term use of this revolutionary treatment is under threat by the
increasing prevalence of antibiotic resistant bacteria. In the United States alone, antibioticresistant bacterial infections contribute to 2 million illnesses and a mortality rate of 35,000 each
year (CDC, 2019). The repercussions associated with the over prescription of unnecessary
antibiotics has led to the push for increasing preventative measures in hospitals (Ventola, 2015).

Examples of Antibiotic Resistant Infections
Opportunistic pathogens such as Pseudomonas aeruginosa have intrinsic resistance to
antibacterial agents through various mechanisms (Lambert, 2001). P. aeruginosa is a highly
adaptable species that can acquire resistance via horizontal gene transfer and mutations. One
source of resistance can be attributed to OprD, an outer membrane porin protein that decreases
the membrane permeability of P. aeruginosa, resulting in a barrier that prevents the penetration
of antibiotics (Azam & Khan, 2018). Furthermore, biofilms of P. aeruginosa consist of an
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extracellular polymeric matrix that contain polysaccharides, lipids, protein, extracellular DNA,
and RNA, all of which aid in its ability to act as a diffusive barrier (Azam & Khan, 2018).
Biofilms, especially those formed by Gram-negative bacteria, are difficult to kill partly due to the
presence of persister cells, which are dormant variants of cells that are tolerant to numerous
antibacterials (Lewis, 2010).
Antibiotic resistance is prevalent in bacteria; however, some strains are of more concern
than others due to both their pathogenicity and prevalence. Bacteria such as Escherichia coli and
Staphylococcus aureus are able to resist antibiotics via efflux pumps and enzymes that break
down antibacterials, amongst other means (Blanco, et al., 2016). Methicillin-resistant
Staphylococcus aureus (MRSA) is a global health concern because it can contribute to infective
endocarditis and sepsis, among other diseases (Hassoun, 2017). According to the CDC, it is
deemed as a serious-threat-level pathogen. There are more than 59,000 MRSA infections
acquired per year and of those, there is a mortality rate of more than 9,000 in the United States
alone (CDC, 2012). Antibiotic therapy can provide treatment and limit the spread of MRSA;
however, studies suggest that control of spread is optimized with the increased use of
surveillance cultures, contact precautions (Farr, 2004), and proper use of antiseptics and
disinfectants (Muthotho, et al.,1995).
The CDC recognizes Clostridium difficile as an urgent-threat-level pathogen due to its
prevalence, mortality rate, and rising resistance to antibiotics. C. difficile is a leading cause of
healthcare related antibiotic-associated diarrhea that infects more than 250,000 patients in the
United States per year, and has an annual mortality rate of 14,000 (CDC, 2014). Often after
antibiotic treatment for other infections the intestinal flora becomes vulnerable to C. difficile
colonization. Due to the rising prevalence of selectively nonsusceptible and multidrug resistant
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strains of C. difficile as well as MRSA (Hassoun, 2017), there has been an increased emphasis on
preventing the transmission of bacterial infections via antiseptics and disinfectants (Ventola,
2015).
Biofilms

Biofilms are communities of bacteria that are able to attach to both biotic and abiotic surfaces
(Hassan, et al., 2011). Biofilm formation and development is characterized by the irreversible
adhesion of biofilm structures where the cells become immobilized through the development of
the extracellular polymeric substance matrix (EPS) (Chadha, 2014). The EPS is consists of
polysaccharides, proteins, lipids, and nucleic acids, all of which contribute to the stability and
adhesive nature of biofilm. Extracellular enzymes in the EPS serve as a means of sequestering
nutrients and energy sources to ensure the survival of the complex (Flemming & Wingender,
2010). The close proximity of cells in the biofilm permits for cell-to-cell communication and
horizontal gene transfer, both of which contribute to the cooperation and adaptability of biofilm
in changing environments (Madsen et al., 2012).
Conditions in the environment that are critical to success during biofilm formation
include optimal temperature, pH, ionic strength, and nutrient availability (Donlan, 2002). Other
mechanisms that contribute to antibiotic resistance in bacteria include the presence of efflux
pumps, slow growth rate of cells, neutralizing enzymes, and altered membrane permeability
(Jamal, et al., 2015).
According to the National Institutes of Health, approximately 65 percent of all microbial
infections and 80 percent of chronic microbial infections are associated with biofilms (Jamal, et
al., 2018). P. aeruginosa is an opportunistic pathogen that is often studied due to its role in
serious infections and disorders such as cystic fibrosis. The ability of P. aeruginosa to form
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biofilms contributes to its virulence and resistance to antibacterials and antibiotics (Mulcahy, et
al., 2008). Biofilms of P. aeruginosa growing on urinary catheters have been found to be 1000
times more resistant to tobramycin than their planktonic counterparts (Nickel, 1985). There are
multiple factors that contribute to biofilm-associated resistance. These include the restricted
diffusion of antibiotics due to the complex nature of the EPS (Drenkard, 2003), drug indifference
of cells (Mulcahy & Lewenza, 2008), and the presence of persister cells (Lewis, 2010).
Lung infections caused by biofilm-forming mucoid strains of P. aeruginosa are
detrimental to patients with cystic fibrosis. By late adolescence approximately 80% of these
patients are chronically infected with P. aeruginosa (Lyczak, et al., 2002), and if also associated
with S. aureus colonization, the rate of morbidity and mortality increases (Silva Filho, 2013).
The human immune system responds to the infection with chronic inflammation, which
ultimately causes damage to airways and lung tissue (Høiby, et al., 2010) and lead to premature
death (Klare, et al., 2016).
A concern throughout hospitals is the presence and persistence of biofilms on indwelling
medical devices. Biofilm formation on indwelling urinary catheters is responsible for many
bloodstream and urinary tract infections (Revdiwala, et al., 2012). Infective endocarditis
stemming from biofilm formation on prosthetic heart valves is another source of concern (Piper,
et al., 2001). Consistently, the top offenders have a high biofilm forming ability and include
Staphylococcus aureus, Pseudomonas aeruginosa, and Enterococcus faecalis (Murugan, et al.,
2015). In acute care units, approximately 80 percent of urinary tract infections (UTIs) are
catheter-associated UTIs. Moreover, the longer the patient is in the hospital, the higher the risk of
developing an infection becomes (Murugan, et al., 2015). Currently, the most effective means of

5
treating conditions associated with biofilm formation is the removal of the contaminated device
(Revdiwala, et al., 2012).
Biomedical devices are an expanding industry and although the technology is increasing
in its sophistication, devices and engineered tissue constructs are still susceptible to microbial
colonization. Hospital acquired infections cost the United States more than $5 billion and of
those approximately 60-70% are related to an implanted medical device. Solutions proposed to
combat biofilm formation on indwelling medical devices include coating catheters with
antibacterial agents, both of which can interfere with biofilm attachment and development. A
promising solution for biofilm formation on ureter polyurethane stents is impregnating the stent
with heparin, an anticoagulant (Dror, et al., 2009). Other possibilities include producing new
antibacterials to use on medical devices and patient rooms to prevent the spread of infection prior
to patient acquisition.

Possible Solutions
With limited funding going towards the development of new antibiotics (Simpkin et al., 2017),
the scientific community is looking for other antibacterial products that can be used against
antibiotic resistant bacteria before they are able to infect a potential host. Synthetic chemical
compounds known as amphiphiles have shown promise in being capable of membrane disruption
(LaDow et al., 2011). Amphiphiles (Figure
1) consist of varying numbers of hydrophilic
head groups and hydrophobic hydrocarbon
tails and likely kill bacteria via cell lysis
Figure 1 A general amphiphile structure,
consisting of both a hydrophilic head and a
hydrophobic tail.

(LaDow et al., 2011). Studies suggest that
amphiphiles are also capable of disrupting
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the proton motive force, impede transmembrane proteins, or produce openings in the membrane,
all of which can lead to cell death (Vudumula, et al., 2012). In consideration of disrupting
biofilms, studies suggest that the compounds may be disturbing the EPS via electrostatic
interactions, and then killing the cells via lysis (Jennings et al., 2014). Currently, several series of
novel tetra-cationic bipyridine amphiphiles are being investigated in our lab for their bactericidal
effects against four Gram-negative bacterial species (Pseudomonas aeruginosa, Escherichia coli,
and Klebsiella pneumoniae, PA2) and four Gram-positive bacterial species (Staphylococcus
aureus, Enterococcus faecalis,
Bacillus anthracis, Bacillus subtilis).
Tetra-cationic bipyridine
Figure 2 The general structure of a tetra-cationic
bipyridinium amphiphile where m represents varying
spacer lengths and n-1 represents varying tail lengths.

amphiphiles vary in the length of the
carbon spacer between head groups,

as well as their hydrocarbon tail lengths (Figure 2).

Specific Aims
The aims of this investigation were to determine the impact of carbon spacer length and tail
length of tetra-cationic bipyridinium amphiphiles on 1. minimum inhibitory concentration, 2.
killing speed, and 3. biofilm disruption. The microbial strains consisted of both Gram-positive
and Gram-negative bacteria. The Gram-positive bacteria utilized were S. aureus, E. faecalis, B.
anthracis, and B. subtilis. Gram-negative bacteria utilized were E. coli, K. pneumoniae, P.
aeruginosa, and hyper-biofilm forming strain of P. aeruginosa, PA2 (Holloway, 1955). The
antibacterial agents used were novel amphiphiles synthesized by the Caran Lab at James
Madison University.
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To investigate the effects of amphiphile structure on antibacterial activity, the minimum
inhibitory concentrations relative to carbon spacer length and tail length were explored. Due to
its importance in combating hospital acquired antibiotic resistant bacteria, analysis of biofilm
disruption was also a major focus of this study. Fast-acting antibacterials are ideal for
minimizing the spread of antibiotic resistant infections; thus another specific aim of this study
was to conduct time kill kinetic assays to explore the rate at which the various amphiphiles were
able to kill microorganisms.
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Chapter 2: The Effect of Tail Length on Antibacterial Activity
2.1 Introduction
Overexposure to antibiotics via overprescribing, agricultural use, and lack of oversight is leading
to a global crisis. Antibiotics were introduced into agriculture after the discovery that they could
promote growth and prevent infection in livestock (Khachatourians, 1998). Although the
percentage of antibiotics going towards the agricultural industry has declined in recent years, it
still accounts for a significant amount of its distribution. Poor oversight and regulatory
management of antibiotics throughout the world, ranging from medicinal to agricultural use, has
led to an increased risk of antibiotic resistant bacteria. Exposure to antibiotics is inevitable due to
the myriad of diverse environments they are released in, including human, veterinary, and
farming waste streams. Antibiotics and their metabolites may seep into soil and groundwater,
furthering their spread and dispersal (Manyi-Loh, et al., 2017). By the year 2050 it is projected
that both globally and annually, antibacterial resistant infections (AMRs) will cause 10 million
deaths per year and have an economic burden of US$100 trillion. Furthermore, the development
of new antibiotics is met with declining urgency due to their logistics, high costs of clinical trials,
and the inevitability of bacteria developing resistance (Roope, et al., 2019). Another
complication lies with the inappropriate distribution of antibiotics. In many nations it is an illegal
practice to sell antibiotics without a prescription. Even so, in a 2019 review of community
pharmacies around the world, 62% of those reviewed were found to distribute antibiotics without
a prescription, with the highest proportion of occurrence in developing countries (Auta, et al.,
2019).
ESKAPE pathogens encompass six bacterial pathogens that are commonly associated
with multidrug resistance and increased virulence. These are: Enterococcus faecium,
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Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas
aeruginosa, and Enterobacter spp. Often multidrug resistance is due to excessive and/or
inappropriate use of antibiotics and poses a severe global threat to human health (Santajit and
Indrawattana, 2016). Due to their high risk, the World Health Organization includes these
bacteria in the list of priority antibiotic resistant pathogens (Tacconelli, et al., 2018).
A critical action to prevent the spread of AMRs is to use antiseptics and disinfectants that
can effectively kill the bacteria. It is thought that because cleaning products typically have nonselective targets such as disruption of the cell membrane (Aboualizadeh, et al., 2017), bacteria
may less easily develop resistance (Venter, et al., 2017). Amphiphiles, synthetic chemical
compounds that kill bacteria via cell lysis, are a possible solution for the prevention of spread of
bacteria, particularly resistant bacteria in the healthcare setting (LaDow, et al., 2011).
Previous studies have researched the antibacterial properties of novel amphiphiles with
structures varying in head, spacer, and tail number and length (Ghallager, et al., 2017; LaDow et
al., 2011; Marafino et al., 2015; Rogers, 2017; Sharpes, 2018). The current series of amphiphiles
are tetra-cationic bipyridinium amphiphiles (Figure 2) that vary in both tail and spacer length.
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2.2 Results and Discussion

Minimum Inhibitory Concentration
Three Gram-negative (E. coli, K. pneumoniae, and P. aeruginosa) and three Gram-positive (B.
anthracis, B. subtilis, and E. faecalis) bacterial strains were tested against amphiphiles with
carbon tail lengths of 6, 8, 10, and 12 carbons (Table 1). The effect of carbon tail length was
evaluated when spacer length was held constant. The spacers evaluated were 6, 9, 12, and 14
carbons in length. MIC values were confirmed with 3 independent experiments.
Upon testing E. coli with a 9-carbon spacer, there was a maximum MIC of 31μM with 6
and 8-carbon tails, while the minimum MIC of 8μM was recorded with 10 and 12-carbon tails.
Other series showed similar trends, however the minimum concentration varied in the tail lengths
such that the minimum MIC was recorded with 8, 10, and 12-carbon tails, depending on the
series. No series had a minimum MIC with a 6-carbon tail (Figure 3A).
When evaluating a tail length of 6 carbons where a 9-carbon spacer was held constant,
the MIC for K. pneumoniae was at a maximum of greater than 500μM, decreased at 8 carbons,
and reached a minimum MIC of 16μM with a 10-carbon tail. The MIC then increased with a 12carbon tail. This trend was consistent with the 6 carbon spacer series, however in the 12 and 14carbon spacer series the minimum MIC recorded with both an 8 and 10-carbon tail (Figure 3B).
In the 12-carbon spacer series at a tail length of both 6 and 8 carbons, the MIC for P.
aeruginosa was at a maximum of 63μM, it decreased to a minimum of 4μM with a 10-carbon
tail, and rose to 16μM with a 12-carbon tail. This trend was consistent in each series with the
exception of the 9-carbon spacer series where the minimum MIC of 16μM was observed with a
12-carbon tail (Figure 3C).
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Upon evaluating a 6 carbon tail length when a 9-carbon spacer was held constant, E.
faecalis was at maximum MIC of greater than 500μM, decreased to 250μM, and reached a
minimum MIC of 8μM with both 10 and 12-carbon tails. A similar trend was noted in all but the
12-carbon spacer series, which recorded a minimum MIC with a 10 carbon tail and increase in
the MIC to 8μM with a 12 carbon tail (Figure 3D).
When evaluating an amphiphile with a 6-carbon tail when a 6-carbon spacer was held
constant, B. anthracis was at maximum MIC of 8μM and a minimum MIC of 4μM with 12carbon tails. A similar trend was noted with the 12-carbon spacer series, yet differed in that the
minimum MIC of 4μM was recorded with 8, 10, and 12-carbon tail. In the 9-carbon and 14carbon spacer series the minimum MIC values were noted with tail lengths ranging from 8 and
10 carbons and 6 to 10 carbons, respectively, followed by a rise in MIC with a 12-carbon tail
(Figure 3E).
Upon testing B. subtilis with a 14-carbon spacer at a tail length of 6 carbons, the MIC
was at a maximum of 16μM, it then decreased to a minimum MIC of 2μM with 8 and 10 carbon
tails, and then increased to 8μM with 12-carbon tails. Similar trends were noted in the other
series, however the MIC remained constant value of 4μM throughout the 12-carbon spacer series
(Figure 3F).
The data suggests that within each series, as the carbon tail length increased the MIC
value decreased, until it reached a point of optimal inhibition, after which the MIC either
increased or remained the same. Overall, the most effective amphiphiles had tail lengths of 10
and 12 carbons.
Previous studies have explored the antibacterial properties of amphiphiles of various
structures. These include but are not limited to tris-cationic amphiphiles with three head groups
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and two hydrocarbon tails (Marafino et al., 2015), tricephalic amphiphiles with a single
hydrocarbon tail (Gallagher et al., 2017), and amphiphiles with two head groups and one
hydrocarbon tail (Ladow et al., 2011). The current data, collected while using tetra-cationic
double-headed, double-tailed amphiphiles show some consistency with previous literature which
sites the optimal tail lengths at 12 to 14-carbons for various amphiphile structures (Gallagher, et
al., 2017; LaDow et al., 2011; Marafino et al., 2015).

Table 1 MIC values assessing the effect of carbon tail length (n) for compounds with spacer
lengths (m) of 6, 9, 12, and 14 carbons. Values were confirmed with 3 independent experiments.
G+ = Gram-positive and G- = Gram-negative. ND = no data.
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Figure 3 (A-G)The effect of carbon tail length on antibacterial activity of the n-B-6-B-n; n-B-9B-n; n-B-12-B-n; n-B-14-B-n series. G+ = Gram-positive and G- = Gram-negative.
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Time Kill
Amphiphiles were tested against two Gram-negative (E. coli and P. aeruginosa) and two Grampositive (S. aureus, B. subtilis) bacteria to determine the bacterial killing speed for select
amphiphiles proven to be most effective for the minimum inhibitory concentration. Bacterial
strains were tested against amphiphiles with carbon tail lengths of 6, 8, 10, and 12 carbons and
the effect of carbon tail length was evaluated when spacer length was held constant at 12, 14, and
16 carbons (Table 2).
In the n-B-12-B-n series, P. aeruginosa was at a maximum kill time of 72 hours with 8
carbon tails, decreased to a minimum of 5 minutes with a 10-carbon tail, and increased to 1 hour
with 12-carbon tails. Similar trends were noticed with the n-B-14-B-n and n-B-16-B-n series
(Figure 4B).
At all tail lengths in the n-B-12-B-n series E. coli was killed at 0 minutes. However, in
the n-B-14-B-n series, it was at a maximum time to kill of 14 hours with 6-carbon tails,
decreased to 1 minute with 10-carbon tails, and reached a minimum of 0 minutes with 12-carbon
tails. Similar trends were noted in the n-B-16-B-n series (Figure 4A).
In the n-B-14-B-n series at a tail length of 6 carbons, B. subtilis was at a maximum kill
time of 72 hours, decreased to 1 hour with 8 carbons, reached a minimum of 0 minutes with 10
carbons, and increased to 1 minute with 12 carbons (Figure 4C). Similar trends in data were
noted with the other series tested.
In the n-B-14-B-n series at a tail length of 8 carbons, S. aureus was at a maximum kill
time of 2 hours and decreased to 30 minutes with 10 carbons (Figure 4D). Similar trends in data
were noted with the other series tested.
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Table 2 Time kill values assessing the effect of carbon tail length (n) for compounds with spacer
lengths (m) of 12, 14, and 16 carbons. Values were confirmed with 2 independent experiments.
G+ = Gram-positive and G- = Gram-negative. ND = no data.
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Figure 4 (A-D) The effect of tail length on time to kill among the n-B-12-B-n; n-B-14-B-n; n-B16-B-n series. G+ = Gram-positive and G- = Gram-negative.

Biofilm Disruption

PA2, a hyper-biofilm forming strain of P. aeruginosa, was tested against amphiphiles with
carbon tail lengths of 8, 10, and 12 carbons. The effect of carbon tail length was evaluated when
spacer length was held constant at lengths of 12 and 14 carbons. Tobramycin, an antibiotic
targeted towards Gram-negative bacteria, particularly Pseudomonas species (Brogden, et.al,
1976), was tested against PA2 and used as a control.
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In the n-B-12-B-n series, the percentage of biofilm disruption was at its peak with 10
carbon tails at 75% at a concentration of 63μM, and decreased to about 50% with 8 and 12
carbon tails at concentrations of 31μM and 63μM, respectively (Figure 5).
In the n-B-14-B-n series, the percentage of biofilm disruption was at its peak with 12carbon tails at 72% at a concentration of 125μM, decreased to 51% with 8-carbon tails, and was
at a minimum of 44% with 10-carbon tails at a concentration of 31μM. When tested, tobramycin
reached its peak disruption of 66% at a concentration of 125μM. In each series tested, as well as
tobramycin, the percent disruption positively increased with the amphiphile concentration, until
its peak, after with the disruption gradually declined (Figure 6).
The data suggest that a 10-carbon tail is most effective for biofilm disruption with PA2 in
concentrations between 63μM and 125μM. Both 10-B-12-B-10 and 12-B-14-B-12 surpassed the
biofilm disruption capabilities of tobramycin at lower concentrations, with the former being the
better of the two. Generally, amphiphile concentrations below 63μM are relatively ineffective
with 50% disruption or less.
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Figure 5 The effect of carbon tail length on biofilm disruption of the n-B-12-B-n series and
tobramycin. Plates were read at 570nm. Error bars indicate the standard deviation of each
concentration.

Figure 6 The effect of carbon tail length on biofilm disruption of the n-B-14-B-n series and
tobramycin. Plates were read at 570 nm. Error bars indicate the standard deviation of each
concentration.
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2.3 Methods
Bacterial Strains and Growth Conditions
The Gram-negative bacterial strains used in this study for the MIC and time kill assays were
Escherichia coli ATCC® 25922™, Pseudomonas aeruginosa ATCC® 27853™, and Klebsiella
pneumoniae. A hyper-biofilm forming strain of P. aeruginosa, PA2, was used for biofilm
disruption studies. All Gram-negative bacterial strains were grown in Luria Bertani (LB) broth
with the exception of K. pneumoniae, which was grown in Mueller Hinton Broth (MHB). The
Gram-positive bacterial strains used for the MIC and time kill assays were Bacillus subtilis,
Bacillus anthracis Sterne, Enterococcus faecalis ATCC® 29212™, and Staphylococcus aureus
subsp. aureus ATCC 29213™. All Gram-positive bacterial strains were grown in MHB with the
exception of E. faecalis, which was grown in Todd Hewitt Broth (THB).

Minimum Inhibitory Concentration
The MIC assay followed a standard protocol set forth by the Clinical Laboratory Standards
Institute (CLSI, 2012) and was used to determine the lowest concentration of an amphiphile that
inhibited bacterial growth. Amphiphiles were serially diluted two-fold, ranging from 500μM to
2μM, and 100μL of each was plated in triplicate in a 96-well microtiter plate. Bacterial cultures
grown overnight at 37°C were diluted in broth media to a concentration of 5x106cfu/mL and
100μL added to each well of a 96-well microtiter plate. Sterile deionized water was used as a
control for bacterial growth. The plates were incubated at 37°C for 72 hours and the MIC was
visually determined as the lowest concentration of amphiphile displaying a lack of visible growth
to the naked eye. Each amphiphile was tested for a minimum of three trials.
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Time Kill
A time kill assay was carried out as previously described (LaDow et al., 2011) to determine the
bacterial killing speed of select amphiphiles with low MIC values. Overnight bacterial cultures
were diluted in broth media to a concentration of 5x106cfu/mL. One hundred microliters of a
1mM amphiphile stock were added to the bacterial suspension to a final concentration of 100μM
and incubated at room temperature. One hundred microliter aliquots were plated on LB agar
plates at 0, 1, 5, 15, 30 minutes, and 1, 2, 24, 48, and 72 hours and incubated for 24 hours at
37°C.

Biofilm Disruption
Biofilm disruption assays were carried out as previously described (O’Toole, 2011) and used to
determine the percent disruption over a range of concentrations for an established biofilm. The
amphiphiles which yielded the lowest MIC values were used to test for biofilm disruption. Strain
PA2 was cultured overnight in LB broth at 37°C and diluted to a concentration of 5x106cfu/mL.
In a 96-well microtiter plate, 100μL of PA2 was added to wells, and 100μL of sterile deionized
water was added to empty bordering wells of the plate as a means of reducing the edge effect
(Shukla, 2017). The plates were incubated at 37°C for 24 hours. In triplicate, 100μL of select
amphiphiles serially diluted at the same concentrations used for the MIC assays, ranging from
500μM to 4μM, were added to each well containing PA2. Sterile deionized water was used as a
control for undisrupted bacterial growth and the plates were incubated at 37°C for 24 hours.
Contents of each plate were rinsed with deionized water and dried for 15 minutes, after which
100μL of crystal violet was added to each well that had PA2 and stained for 15 minutes at room
temperature. The crystal violet was then removed and rinsed with deionized water 3 times and
allowed to dry for 40 minutes. One hundred microliters of 95% ethanol was then added to each
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well and incubated at room temperature with shaking (120rpm) for 1 hour. The subsequent
ethanol/stain combination of in each well of the 96-well microtiter plate was transferred to a
clean 96-well microtiter plate and its absorbance determined via a microplate reader set at 570
nm. The absorbency values of the treated wells were compared to the control wells to determine
the percent biofilm disruption.

2.4 Conclusions
As the carbon spacer length was held constant, the antibacterial effects of carbon tail length were
evaluated. When testing the MIC, for both Gram-positive and Gram-negative bacteria, the
optimal tail length ranged from 10 to 12 carbons. Higher MIC values was noted with Gramnegative bacteria, in comparison to Gram-positive species. Upon investigating the speed at which
the varying amphiphiles kill bacteria via time kill kinetics, it was found that tail lengths of 10 to
12 carbons were the most effective. Biofilm disruption assays yielded 10 carbon tailed
amphiphiles to be most effective, with 10-B-12-B-10 exhibiting the highest percentage
disruption at peak concentrations. In general 8 and 12-carbon tailed series were not as effective.
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Chapter 3: The Effect of Spacer Length on Antibacterial Activity
3.1 Introduction
Antibacterial resistance is inevitable, and the losing evolutionary arms race of antibiotics to
antibacterial resistance is evident with the 2.8 million cases and more than 35,000 related deaths
per year in the United States alone. In the modern day and age of global travel, the spread of
AMRs has become even easier, thus the ability to better detect, improve antibiotic usage, and
contain the spread of pathogens is critical (CDC, 2019). If not dealt with in a constructive and
timely manner, modern medicine may be forced to find and implement new approaches to treat
resistant bacterial infections (Ghosh, et al., 2019). Better means of hygiene via the use of
antiseptics and disinfectants may delay the incidence of resistance, especially since many postoperative cases of infection are associated with normal skin flora and indwelling medical devices
(Gilbert & Moore, 2005).
Amphiphiles are known to exhibit antibacterial activity and are effective against both
Gram-negative and Gram-positive bacteria. They are promising candidates for antiseptic and
disinfectant use (Haldar, et al., 2005) and are of minor concern for causing resistance (Gilbert &
Moore, 2005). While previous studies suggest the optimal tail length of similar amphiphiles to be
at 12 to 14-carbons (Gallagher, et al., 2017; LaDow et al., 2011; Marafino et al., 2015), less is
known about the optimal length between two head groups, especially in regards to the current
structure.
Four series of tetra-cationic bipyridinium amphiphiles (6-B-m-B-6; 8-B-m-B-8; 10-B-mB-10; and 12-B-m-B-12), each with varying carbon spacers, were investigated with the aim of
determining optimal spacer length in regards to MIC, time kill, and biofilm disruption.
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3.2 Results & Discussion

Minimum Inhibitory Concentration

Three Gram-negative (E. coli, K. pneumoniae, and P. aeruginosa) and three Gram-positive (B.
anthracis, B. subtilis, and E. faecalis) bacterial strains were tested against amphiphiles with
spacer lengths between 5 and 16 carbons and the effect of spacer length was evaluated when
carbon tail length was held constant at 6, 8, 10, and 12 carbons (Table 3).
Upon testing each series against E. coli, the MIC decreased with increasing spacer length,
reaching a minimum of 4μM between 11 and 16 carbons for both the 10 and 12-bipyridinium
series (10-B-m-B-10 and 12-B-m-B-12, respectively). A minimum MIC of 8μM was achieved
with 12 and 14-carbon spacers in the 6-bipyridinium series. In the 8-bipyridinium series, the
MIC was at a maximum of 63μM with 6 and 8-carbon spacers, decreased to a minimum of 2μM
with a 12-carbon spacer, then increased to 4μM with a 14-carbon spacer (Figure 7A).
In the 6-bipyridinium series of K. pneumoniae at spacer lengths of 8 and 9 carbons, the
MIC was greater than 500μM, progressively decreased to 125μM with a 12-carbon spacer, and
was at a minimum of 63μM with a 14-carbon spacer. In the 8-bipyridinium series, a maximum
MIC of 500μM was recorded with a 6-carbon spacer, decreased to 63μM with a 10-carbon
spacer, and reached a minimum of 4μM with 12, 14, and 16-carbon spacers. In the 10bipyridinium series, a maximum MIC of 31μM was recorded with 5, 6, and 8-carbon spacers,
then a decrease to 16μM with a 9-carbon spacers, and reaching a minimum MIC of 4μM with 11,
12, 14, and 16-carbon spacers. In the 12-bipyridinium series the MICs had a similar trend and
reached a minimum of 8μM with a 12-carbon spacer, then progressively increased to 31μM with
a 16-carbon spacer (Figure 7B).
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When testing P. aeruginosa with the 8-bipyridinium tail series the MIC was greater than
500μM at a spacer length of 6 carbons, decreased to 63μM with a 12-carbon spacer, and was at a
minimum of 8μM with 14 carbons. Similar trends were noted with the 10-bipyridinium series,
with an MIC of 4μM with both the 12 and 14-carbon spacers. The MIC then increased to 8μM
with a 16-carbon spacer (Figure 7C).
In the 8-bipyridinium series tested against E. faecalis, the MIC was at a maximum of
250μM with 6 and 9-carbon spacers, decreased to 31μM with a 12 carbon spacer, and reached a
minimum of 8μM with a 14-carbon spacer. In the 10-bipyridinium series a maximum MIC of
8μM was recorded with spacer lengths of 5 to 11 carbons, and a minimum MIC of 4μM was
achieved with 12, 14, and 16 carbon spacers. In the 12-bipyridinium series, an MIC of 8μM was
maintained throughout the entire series, with the exception of a 14-carbon spacer where the MIC
was 4μM (Figure 7D)
In the 12-bipyridinium series tested against B. anthracis, a maximum MIC of 8μM was
noted with spacer lengths between 6 and 10 carbons. The MIC decreased to a minimum of 2μM
with an 11-carbon tail, and progressively increased to 8μM with 14 and 16-carbon spacers.
Similar trends were noted throughout the 8-bipyridinium series, with minimum MICs of 2μM
achieved at optimal spacer lengths. In the 10-bipyridinium series, an MIC of 2μM was
maintained throughout the entire series with the exception of the 12-carbon spacer where the
MIC was 4μM (Figure 7E).
When tested against B. subtilis, the 8-bipyridinium series the MIC was at a maximum of
16μM with a 6-carbon spacer, decreased to 4μM with spacer lengths of 9 to 12 carbons, and
reached a minimum of 2μM with a 14-carbon spacer. In the 10-bipyridinium series, the MIC was
at a maximum of 4μM with 5 and 6-carbon spacers, and decreased to a minimum of 2μM with 9
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to 16-carbon spacers. The exception to this was with a 12-carbon spacer where the MIC was
recorded at 4μM. In the 12-bipyridinium series, a maximum MIC of 16μM was recorded with a
16-carbon spacer, while the minimum MIC was 2μM with an 11-carbon spacer (Figure 7F).
The data suggests that within each series, as the carbon spacer length increased, the MIC
value decreased until it reached its limit, typically at 11, 12, and 14 carbons, after which the MIC
value plateaued or began to increase.
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Table 3 MIC values assessing the effect of carbon spacer length (m) for compounds with tail
lengths (n) of 6, 8, 10, and 12 carbons. Values were confirmed with 3 independent experiments.
G+ = Gram-positive and G- = Gram-negative. ND = no data.
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Figure 7 (A-G) The effect of spacer length on antibacterial activity of the 6-B-m-B-6; 8-B-m-B8; 10-B-m-B-10; 12-B-m-B-12 series. G+ = Gram-positive and G- = Gram-negative.
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Time Kill

Amphiphiles were tested against two Gram-negative (E. coli and P. aeruginosa) and two Grampositive (S. aureus and B. subtilis) bacteria to determine the bacterial killing speed for select
amphiphiles proven to be most effective according to the MIC. Bacterial strains were tested
against amphiphiles with carbon spacer lengths of 12, 14, and 16 carbons. The effect of carbon
spacer length was evaluated when tail length was held constant at 8, 10, and 12 carbons (Table
4).
When tested against E. coli in the 10-B-m-B-10 series, the time to kill was at a maximum
of 30 minutes with an 11-carbon spacer, decreased to approximately 0 minutes with a 12-carbon
spacer, and increased to 1 and 5 minutes with 14 and 16-carbons, respectively. The 12-B-m-B-12
series had consistent trends with a kill time of approximately 0 minutes with a 12-carbon spacer
(Figure 8A).
P. aeruginosa, tested against the 10-B-m-B-10 series, was at a maximum kill time of 30
minutes with an 11 carbons spacer, decreased to 5 minutes with 12 and 14 carbons, and increased
to 30 minutes with 16 carbons. This trend was consistent with all spacer lengths tested (Figure
8B).
In the 10-B-m-B-10 series at a spacer length of 11 carbons, B. subtilis was at a maximum
kill time of 30 minutes, decreased to a minimum of approximately 0 minutes with 12 and 14
carbons, and increased to 2 hours with 16 carbons. Trends were consistent through each of the
tested series (Figure 8C).
S. aureus, tested against the 10-B-m-B-10 series, was at a maximum kill time of 24 hours
with an 11 carbon spacer, and reached minimum times of 30 minutes at spacer lengths of 12 and
14 carbons. Comparable trends were seen in each of the tested series (Figure 8D).

29
Table 4 Time kill values assessing the effect of carbon spacer length (m) for compounds with
tail lengths (n) of 6, 8, 10, and 12 carbons. Values were confirmed with 2 independent
experiments. G+ = Gram-positive and G- = Gram-negative. ND = no data.
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Figure 8 (A-D) The effect of carbon spacer length on time to kill of the 8-B-m-B-8; 10-B-m-B10; 12-B-m-B-10 series. G+ = Gram-positive and G- = Gram-negative.
Biofilm Disruption
PA2, a hyper-biofilm forming strain of P. aeruginosa, was tested against amphiphiles with
carbon spacer lengths of 12 and 14 carbons. The effect of carbon spacer length was evaluated
when tail length was held constant at lengths of 8, 10, and 12 carbons.
In the 8-B-m-B-8 series, the percentage of biofilm disruption was at its peak with 12 and
14-carbon spacers around 50% at concentrations of 31μM, and decreased to 47% with a 16carbon spacer at a concentration of 31μM (Figure 9).
In the 10-B-m-B-10 series, the percentage of biofilm disruption was at its peak with a 12
carbon spacer at 75% at a concentration of 63μM, decreased to 44% with a 14-carbon spacer at a

31
concentration of 63μM, and reached a minimum disruptions of 41% and 32% with 11 and 16carbon spacers, respectively at concentrations of 63μM (Figure 10).
In the 12-B-m-B-12 series, the percentage of biofilm disruption was at its peak with a 14
carbon spacer at 72% at a concentration of 125μM, decreased to 62% with a 12-carbon spacer at
a concentration of 125μM, and reached a minimum disruption of 60% with an 11-carbon spacer
at a concentration of 250μM. When tested, tobramycin reached its peak disruption of 66% at a
concentration of 125μM (Figure 11).

Figure 9 The effect of carbon spacer length on biofilm disruption of the 8-B-m-B-8 series and
tobramycin. Plates were read at 570 nm. Error bars indicate the standard deviation of each
concentration.
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Figure 10 The effect of carbon spacer length on biofilm disruption of the 10-B-m-B-10 series
and tobramycin. Plates were read at 570 nm. Error bars indicate the standard deviation of each
concentration.

Figure 11 The effect of carbon spacer length on biofilm disruption of the 12-B-m-B-12 series
and tobramycin. Plates were read at 570 nm. Error bars indicate the standard deviation of each
concentration.
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3.3 Methods
Bacterial Strains and Growth Conditions
The Gram-negative bacterial strains used in this study for the MIC and time kill assays were
Escherichia coli ATCC® 25922™, Pseudomonas aeruginosa ATCC® 27853™, and Klebsiella
pneumoniae. A hyper-biofilm forming strain of P. aeruginosa, PA2, was used for biofilm
disruption studies. All Gram-negative bacterial strains were grown in Luria Bertani (LB) broth
with the exception of K. pneumoniae, which was grown in Mueller Hinton Broth (MHB). The
Gram-positive bacterial strains used for the MIC and time kill assays were Bacillus subtilis,
Bacillus anthracis Sterne, Enterococcus faecalis ATCC® 29212™, and Staphylococcus aureus
subsp. aureus ATCC 29213™. All Gram-positive bacterial strains were grown in MHB with the
exception of E. faecalis, which was grown in Todd Hewitt Broth (THB).

Minimum Inhibitory Concentration
The MIC assay followed a standard protocol set forth by the Clinical Laboratory Standards
Institute (CLSI, 2012) and was used to determine the lowest concentration of an amphiphile that
inhibited bacterial growth. Amphiphiles were serially diluted two-fold, ranging from 500μM to
2μM, and 100μL of each was plated in triplicate in a 96-well microtiter plate. Bacterial cultures
grown overnight at 37°C were diluted in broth media to a concentration of 5x106cfu/mL and
100μL added to each well of a 96-well microtiter plate. Sterile deionized water was used as a
control for bacterial growth. The plates were incubated at 37°C for 72 hours and the MIC was
visually determined as the lowest concentration of amphiphile displaying a lack of visible growth
to the naked eye. Each amphiphile was tested for a minimum of three trials.
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Biofilm Disruption
Biofilm disruption assays were carried out as previously described by O’Toole (2011) and were
used to determine the percent disruption over a range of concentrations for an established
biofilm. The amphiphiles which yielded the lowest MIC values were used to test for biofilm
disruption. PA2 was cultured overnight in LB broth at 37°C and diluted to a concentration of
5x106cfu/mL. In a 96-well microtiter plate, 100μL of PA2 was added to wells, and 100μL of
sterile deionized water was added to empty bordering wells of the plate as a means of reducing
the edge effect (Shukla, 2017). The plates were incubated at 37°C for 24 hours. In triplicate,
100μL of select amphiphiles were serially diluted at the same concentrations used for the MIC
assays, ranging from 500μM to 4μM, were added to each well containing PA2. Sterile deionized
water was used as a control for undisrupted bacterial growth and the plates were incubated at
37°C for 24 hours. The contents of each plate were rinsed with deionized water and dried for 15
minutes, after which 100μL of crystal violet was added to each well that had PA2 and stained for
15 minutes at room temperature. The crystal violet was then removed and rinsed with deionized
water three times and allowed to dry for 40 minutes. One hundred microliters of 95% ethanol
was then added to each well and incubated at room temperature with shaking (120rpm) for 1
hour. The subsequent ethanol/stain combination in each well of the 96-well microtiter plate was
transferred to a clean 96-well microtiter plate and its absorbance determined via a microplate
reader set at 570 nm. The absorbency values of the treated wells were compared to the control
wells to determine the percent biofilm disruption.

Time Kill
A time kill assay was carried out as described by LaDow et al. (2011) to determine the bacterial
killing speed of select amphiphiles with low MIC values. Overnight bacterial cultures were
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diluted in broth media to a concentration of 5x106cfu/mL. One hundred microliters of a 1mM
amphiphile stock were added to the bacterial suspension to a final concentration of 100μM and
incubated at room temperature. One hundred microliter aliquots were plated on LB agar plates at
0, 1, 5, 15, 30 minutes, and 1, 2, 24, 48, and 72 hours and incubated for 24 hours at 37°C.

3.4 Conclusions
The effects of carbon spacer length were evaluated when carbon tail length was held constant. As
carbon spacer length increased the MIC values decreased. Typically, spacer lengths of 12 and 14
carbons were the most effective and Gram-negative bacteria had higher MIC values when
compared to Gram-positive bacteria, which is unsurprising due to the structural differences of the
two cell types (Silhavy. et al., 2010). These spacer lengths were also found to be most effective
when investigating time kill. Upon evaluating their biofilm disrupting effects, amphiphiles with
spacer lengths of 12 and 14 carbons were generally comparable to tobramycin, an antibiotic
often used when combating Pseudomonas species (Brogden, et al., 1976). At low concentrations
of 4μM and 8μM, 10-B-12-B-10 and 12-B-14-B-12 surpassed the biofilm disrupting capabilities
of tobramycin.
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Chapter 4: Conclusions
The goal of this research was to determine the impact of amphiphile structure on the MIC, time
kill, and biofilm disruption. An increase in length of either of these carbon chains may increase
the flexibility of the compounds and allow them to better penetrate bacterial membranes.
Generally the MIC values were higher when treating Gram-negative bacteria, as
compared to Gram-positive bacteria, which is unsurprising due to the structural membrane
differences of the two cell types (Silhavy. et al., 2010). In this study, optimal tail lengths were 10
and 12 carbons, which has some overlap with previous studies citing optimal tail lengths to be at
12 and 14 carbons (Gallagher, et al., 2017; LaDow et al., 2011; Marafino et al., 2015; Rogers,
2017; Sharpes, 2018). Previous studies have investigated amphiphiles of varying structures
including bicephalic amphiphiles with an aromatic core and spacer lengths of 4, 5, and 6 carbons
(LaDow, et al., 2011), tris-cationic amphiphiles with three heads, two tails, and no spacer
(Marafino, et al., 2015), and three cationic heads and a single tail (Gallagher, et. al., 2017). The
spacer lengths of previous studies in this lab are not quite comparable due to structural
differences. However optimal spacer lengths in this study were 12 and 14 carbons.
Killing bacteria at faster speeds may aid in the prevention of spread of infections and
possibly resistant bacteria (McDonnell & Russell, 1999). Upon investigating the structural
impact of bacterial killing, tail lengths of 10 and 12 carbons, and spacer lengths of 12 and 14
carbons were the most effective. These findings are consistent with the hydrocarbon chain
lengths when evaluating the MIC. Both 10-B-12-B-10 and 10-B-14-B-10 were able to kill three
out of the four bacteria in 5 minutes or less, with S. aureus taking 30 minutes. 8-B-16-B-8
followed the same trend but S. aureus had a time kill of 1 hour. No distinct pattern among
different spacer and tail series were noted, thus an evaluation of biofilm disruption is most
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accurate when evaluating the combination of tail and spacer length, rather than its individual
components. The only two amphiphiles that were more effective than tobramycin, an antibiotic
targeted towards the Pseudomonas species (Brogden, et.al, 1976), were 10-B-12-B-10 and 12-B14-B-10. Due to their ability to disrupt established biofilms, these compounds may prove to be
effective disinfectants and aid in the prevention of both resistant and non-resistant bacterial
infections. All other tested amphiphiles were unable to consistently surpass even 60% disruption
at any concentration.
When considering MIC, time kill, and biofilm disruption, the most effective compounds
were 10-B-12-B-10, 10-B-14-B-10, and 12-B-14-B-12. Both had low MIC values that are
capable of killing bacteria rapidly and at relatively high biofilm disrupting rates. Future
directions of research may include identification of synergistic combinations that enhance the
overall effect the amphiphiles in pursuit of novel antiseptics and disinfectants.
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Chapter 5: Scanning Electron Microscopy
5.1 Scanning Electron Microscopy
The cationic nature of many antibacterials allow them to penetrate and disrupt the net negative
charge of bacterial cells (Gilbert & Moore, 2005). Four main hypotheses are used to describe the
antibacterial nature of cationic amphiphiles; barrel-stave model, toroidal pore model, disordered
toroidal pore model, and carpet-detergent mechanism (Ong, et al., 2014. According to the barrelstave model, antibacterial peptides (AMPs) are perpendicularly inserted into the membrane
bilayer, forming pores. In the toroidal pore model the AMPs are perpendicularly aligned with the
membrane but causes an inward folding of the membrane lipids, yielding open channels. In the
disordered toroidal pore model, the AMPs align parallel to the membrane to form pores, but this
mechanism it results in less regular pore formation. Lastly, in the carpet-detergent mechanism,
after surpassing a threshold concentration, the AMPs align parallel to the membrane, leading to
its permeation and dispersion in a detergent-like manner where no distinct pores are formed
(Ong, et al., 2014). It is hypothesized that by increasing the spacer length, the amphiphiles will
become better able to permeate the cell membrane.
It has been hypothesized that amphiphiles work via pore formation in the cell
membranes, leading to cell lysis and death (Gilbert & Moore, 2005). Preliminary images via
scanning electron microscopy (SEM) were acquired. SEM was used to image bacteria under both
control and treated conditions for both Gram-positive and Gram-negative bacteria. E. faecalis
was imaged when treated under control conditions (deionized water) (Figure 12A) and treated
with the amphiphile 10-B-14-B-10 at a concentration of 8μM (Figure 12B). Under control
conditions E. faecalis is intact, but under amphiphile treatment the bacteria have pores and many
cells appear to no longer be intact. E. coli was imaged when treated under control conditions
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(deionized water) (Figure 13A) with the amphiphile 8-B-14-B-8 at a concentration of 8μM
(Figure 13B). Under control conditions E. coli is intact, but under amphiphile treatment the
bacteria have been lysed and are no longer intact.
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Figure 12 SEM images of E. faecalis under (A) control conditions and (B) treated with 10-B-14B-10 at 8μM. Red arrows indicate examples of poration in treated E. faecalis cells. Images
acquired with a Zeiss scanning electron microscope.
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Figure 13 SEM images of E. coli under (A) control conditions and (B) treated with 8-B-14-B-8
at 8μM where the amphiphile successfully lysed the E. coli cells.
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5.2 Methods

Preparation of samples for SEM imaging were carried out using a modified protocol as
previously described (Murtey & Ramasamy, 2016). Bacterial cultures grown overnight at 37°C
were diluted in broth media to a concentration of 5x106cfu/mL. In preparation for treatment,
250μL of the bacteria stock and 250μL of treatment (deionized water or amphiphile treatment)
were combined and incubated at 37°C for 72 hours. Cells were fixed using 2% glutaraldehyde
followed by a deionized water wash. An ethanol dehydration process followed and included
increasing ethanol concentrations up to 100% ethanol. Several 1μL droplets were added to a slide
and allowed to air dry for 24 hours. Samples were coated with gold and imaged by SEM.
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